1-7 of 7
Thomas H. Carter, MD, PhD
Close
Sort by
Journal Articles

Adverse Prognostic Impact of GAS6 Expression in De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (CALGB 8461, 9665, 20202; Alliance)

Susan Whitman, PhD, Jessica Kohlschmidt, PhD, Kati Maharry, MAS, Deedra Nicolet, MS, Sebastian Schwind, MD, Heiko Becker, MD, Klaus H. Metzeler, MD, Krzysztof Mrózek, MD, PhD, Jason H. Mendler, MD, PhD, Ann-Kathrin Eisfeld, MD, Stefano Volinia, PhD, Bayard L. Powell, MD, Thomas H. Carter, MD, PhD, Jonathan E. Kolitz, MD, Richard M. Stone, MD, Il-Kyoo Park, Michael A. Caligiuri, M.D., Guido Marcucci, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2012) 120 (21): 1293.
https://doi.org/10.1182/blood.V120.21.1293.1293
Published: 2012
Journal Articles

Poor Outcome of RUNX1 -Mutated ( RUNX1 -mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures,

Jason H. Mendler, MD, PhD, Kati Maharry, MAS, Michael D. Radmacher, PhD, Krzysztof Mrózek, MD, PhD, Jessica Kohlschmidt, PhD, Deedra Nicolet, MS, Heiko Becker, MD, Klaus H. Metzeler, MD, Sebastian Schwind, MD, Susan P. Whitman, PhD, William Blum, MD, Bayard L. Powell, MD, Jonathan E. Kolitz, MD, Thomas H. Carter, MD, PhD, Meir Wetzler, MD, Joseph O. Moore, MD, Andrew J. Carroll, PhD, Maria R. Baer, MD, Richard A. Larson, MD, Michael A Caligiuri, MD, Guido Marcucci, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2011) 118 (21): 3454.
https://doi.org/10.1182/blood.V118.21.3454.3454
Published: 2011
Journal Articles

ASXL1 Mutations Identify a High-Risk Subgroup of Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia within the European LeukemiaNet ‘Favorable' Genetic Category

Klaus H. Metzeler, MD, Heiko Becker, MD, Kati Maharry, MAS, Michael D. Radmacher, PhD, Jessica Kohlschmidt, PhD, Krzysztof Mrózek, MD, PhD, Deedra Nicolet, MS, Susan P. Whitman, PhD, Yue-Zhong Wu, MS, Sebastian Schwind, MD, Bayard L. Powell, MD, Thomas H. Carter, MD, PhD, Meir Wetzler, MD, Joseph O. Moore, MD, Jonathan E. Kolitz, MD, Maria R. Baer, MD, Andrew J. Carroll, PhD, Richard A. Larson, MD, Michael A Caligiuri, MD, Guido Marcucci, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2011) 118 (21): 417.
https://doi.org/10.1182/blood.V118.21.417.417
Published: 2011
Journal Articles

MiR-3151 , a Novel MicroRNA Embedded in BAALC , Is Only Weakly Co-Expressed with Its Host Gene and Independently Impacts on the Clinical Outcome of Older Patients (Pts) with De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)

Ann-Kathrin Eisfeld, MD, Guido Marcucci, MD, Kati Maharry, MAS, Sebastian Schwind, MD, Michael D. Radmacher, PhD, Deedra Nicolet, MS, Heiko Becker, MD, Susan P. Whitman, PhD, Klaus H. Metzeler, MD, Krzysztof Mrózek, MD, PhD, Yue-Zhong Wu, MS, Maria R. Baer, MD, Bayard L. Powell, MD, Thomas H. Carter, MD, PhD, Joseph O. Moore, MD, Jonathan E. Kolitz, MD, Meir Wetzler, MD, Michael A Caligiuri, MD, Richard A. Larson, MD, Stephan M. Tanner, PhD, Albert de la Chapelle, MD, PhD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2011) 118 (21): 1462.
https://doi.org/10.1182/blood.V118.21.1462.1462
Published: 2011
Journal Articles

Mutations In the Tet Oncogene Family Member 2 ( TET2 ) Gene Refine the New European LeukemiaNet Risk Classification of Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) In Adults: A Cancer and Leukemia Group B (CALGB) Study

Klaus H. Metzeler, MD, Kati Maharry, MAS, Michael D. Radmacher, PhD, Krzysztof Mrózek, MD, PhD, Dean Margeson, MAS, Heiko Becker, MD, John Curfman, Kelsi B. Holland, MS, Sebastian Schwind, MD, Susan P. Whitman, PhD, Yue-Zhong Wu, MS, William Blum, MD, Bayard L. Powell, MD, Thomas H. Carter, MD, PhD, Meir Wetzler, MD, Joseph O. Moore, MD, Jonathan E. Kolitz, MD, Maria R. Baer, MD, Andrew J. Carroll, PhD, Richard A. Larson, MD, Michael A. Caligiuri, MD, Guido Marcucci, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2010) 116 (21): 98.
https://doi.org/10.1182/blood.V116.21.98.98
Published: 2010
Journal Articles

Dendritic Cell Reconstitution Following Autologous Stem Cell Transplant with GM-CSF Support for Multiple Myeloma.

Annette J. Schlueter, MD, PhD, Judith K. Glasgow, BS, Werner Wilke, MD, PhD, Jacquie R. Marietta, MS, Raymond J. Hohl, MD, PhD, Thomas H. Carter, MD, PhD, Roger D. Gingrich, MD, PhD, Margarida D. Magalhaes-Silverman, MD
Journal: Blood
Blood (2007) 110 (11): 951.
https://doi.org/10.1182/blood.V110.11.951.951
Published: 2007
Journal Articles

Dendritic Cell Reconstitution Following Autologous Stem Cell Transplant for Multiple Myeloma.

Annette J. Schlueter, MD, PhD, Judith K. Glasgow, BS, Werner W. Wilke, MD, PhD, Jacquie R. Marietta, BS, Raymond J. Hohl, MD, PhD, Thomas H. Carter, MD, PhD, Roger D. Gingrich, MD, PhD, Margarida D. Magalhaes-Silverman, MD
Journal: Blood
Blood (2005) 106 (11): 5212.
https://doi.org/10.1182/blood.V106.11.5212.5212
Published: 2005